Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
25000 participants
OBSERVATIONAL
2020-12-20
2026-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Parkinson's Disease Genetics Database
NCT00855556
PROGENI (Parkinson's Research: The Organized Genetics Initiative) Family Study of LRRK2 (Leucine-rich Repeat Kinase 2)
NCT01536821
Neurogenetics Patient Registry
NCT02995538
The Parkinson's Disease NeuroGenebank at Scripps Clinic Registry
NCT00766948
Assessing the Polygenic Burden of Rare Disruptive Mutations in Parkinson's Disease
NCT04620980
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lab Assay for seven genetic variants for Parkinson's Disease
Counseling provided to participant by site clinician/physician/genetic counselor.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Meet Movement Disorder Society (MDS) Clinical Diagnostic Criteria for Parkinson's Disease: probable diagnosis.
2. Willingness to undergo genetic testing, and choose to be informed of genetic testing results for GBA, LRRK2 and 5 additional PD related genes (SNCA, VPS35, PRKN, PINK-1, PARK7).
3. Capacity to give full informed consent in writing or electronically, and have read and signed the informed consent forms (ICFs) based on site clinician's determination.
4. Able to perform study activities (including completion of either online, in-person or paper surveys).
Study Population 2: People at risk of developing PD (not open for recruitment)
1\. Family members of Study Population 1 may be invited to participate in the study if confirmatory genetic testing is deemed necessary by the genetic testing laboratory.
Exclusion Criteria
2. Individuals who have received a blood transfusion within the past 3 months.
3. Individuals who have active hematologic malignancies such as lymphoma or leukemia.
4. Individuals who have had a bone marrow transplant within the past 5 years.
5. Under the age of 18
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Indiana University
OTHER
Fulgent Genetics
UNKNOWN
The Parkinson Study Group
NETWORK
Parkinson's Foundation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
James Beck, PhD
Role: PRINCIPAL_INVESTIGATOR
Parkinson's Foundation
Roy N Alcalay, MS, MD
Role: PRINCIPAL_INVESTIGATOR
Tel Aviv Sourasky Medical Center, Columbia University Irving Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Alabama Birmingham
Birmingham, Alabama, United States
MD First Research
Chandler, Arizona, United States
Barrow Neurological Institute
Phoenix, Arizona, United States
University of Arkansas
Fayetteville, Arkansas, United States
University of California San Diego (UCSD)
La Jolla, California, United States
University of California Los Angeles
Los Angeles, California, United States
University of California San Francisco (UCSF)
San Francisco, California, United States
University of Colorado Anschutz
Aurora, Colorado, United States
Hartford Healthcare
Hartford, Connecticut, United States
Aventura Neurology - Visionary Investigators Network
Aventura, Florida, United States
Parkinson's Disease & Movement Disorder Center of Boca Raton
Boca Raton, Florida, United States
University of Florida
Gainesville, Florida, United States
University of Miami
Miami, Florida, United States
Cleveland Clinic Weston
Weston, Florida, United States
Morehouse College
Atlanta, Georgia, United States
The Queen's Health System
Honolulu, Hawaii, United States
University of Illinois-Chicago
Chicago, Illinois, United States
Rush University
Chicago, Illinois, United States
University of Chicago
Chicago, Illinois, United States
Northwestern University
Evanston, Illinois, United States
Indiana University
Indianapolis, Indiana, United States
University of Iowa
Iowa City, Iowa, United States
University of Kansas
Lawrence, Kansas, United States
University of Kentucky
Lexington, Kentucky, United States
Louisiana State University
Shreveport, Louisiana, United States
Johns Hopkins
Baltimore, Maryland, United States
University of Maryland
College Park, Maryland, United States
Massachusetts General Hospital (MGH)
Boston, Massachusetts, United States
BMC Community Hospital
Boston, Massachusetts, United States
Beth Israel Deaconess Medical Center (BIDMC)
Boston, Massachusetts, United States
Struthers Parkinson's Center - HealthPartners Park Nicollet
Golden Valley, Minnesota, United States
Rutgers University
New Brunswick, New Jersey, United States
University of New Mexico
Albuquerque, New Mexico, United States
New York University
New York, New York, United States
Mount Sinai
New York, New York, United States
Columbia University
New York, New York, United States
University of North Carolina - Chapel Hill
Chapel Hill, North Carolina, United States
Atrium Health
Charlotte, North Carolina, United States
University of Cincinnati
Cincinnati, Ohio, United States
Case Western Reserve University
Cleveland, Ohio, United States
Cleveland Clinic
Cleveland, Ohio, United States
Ohio State University
Columbus, Ohio, United States
Oregon Health and Science University
Portland, Oregon, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Thomas Jefferson University
Philadelphia, Pennsylvania, United States
Medical University of South Carolina
Charleston, South Carolina, United States
Vanderbilt University
Nashville, Tennessee, United States
Baylor College of Medicine
Houston, Texas, United States
University of Texas at San Antonio
San Antonio, Texas, United States
Intermountain Health
Murray, Utah, United States
Virginia Commonwealth University
Richmond, Virginia, United States
Evergreen Health
Kirkland, Washington, United States
Inland Northwest Research
Spokane, Washington, United States
Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Toronto Western Hospital
Toronto, Ontario, Canada
Tel Aviv Sourasky Medical Center
Tel Aviv, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PDGENE-PF
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.